Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

CareDx, Inc. - Common Stock (NQ:CDNA)

14.97 +0.27 (+1.84%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
From CareDx, Inc.
Via Business Wire
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
From CareDx, Inc.
Via Business Wire
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
From CareDx, Inc.
Via Business Wire
4 Analysts Assess CareDx: What You Need To Know
 
Via Benzinga
Earnings Scheduled For August 6, 2025
 
Via Benzinga
Earnings Scheduled For April 30, 2025
 
Via Benzinga
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
From CareDx, Inc.
Via Business Wire
CareDx Issues Comment Letter on Draft LCD Policy
From CareDx, Inc.
Via Business Wire
CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential
CareDx, Inc. faces uncertainty with proposed reimbursement changes, but has long-term potential in the $8 billion transplant solutions market. 
Via Benzinga
This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
 
Via Benzinga
CareDx to Participate in Wells Fargo Healthcare Conference
From CareDx, Inc.
Via Business Wire
CareDx (CDNA) EPS Beats Sales Gain 14%
Via The Motley Fool
CareDx Inc (NASDAQ:CDNA) Posts Mixed Q2 2025 Results Amid Revenue Adjustments and Testing Growth
CareDx Inc (CDNA) reported mixed Q2 2025 results with revenue of $86.7M, missing estimates, but adjusted revenue rose 14% YoY. Testing volumes grew 13%, while shares fell 6.8% post-earnings. 
Via Chartmill
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer
From CareDx, Inc.
Via Business Wire
CareDx Announces Second Quarter 2025 Financial Results
From CareDx, Inc.
Via Business Wire
CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation
From CareDx, Inc.
Via Business Wire
CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress
From CareDx, Inc.
Via Business Wire
CareDx to Report Second Quarter 2025 Financial Results
From CareDx, Inc.
Via Business Wire
CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection
From CareDx, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Here are the top movers in Thursday's session.
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements. 
Via Chartmill
Gapping stocks in Thursday's session
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings
 
Via Benzinga
Topics Stocks
CareDx Announces Repurchase of 5% of Outstanding Shares
From CareDx, Inc.
Via Business Wire
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
From Johnson Fistel, PLLP
Via Business Wire
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
Analyst Expectations For CareDx's Future
 
Via Benzinga
CareDx Reports First Quarter 2025 Results
From CareDx, Inc.
Via Business Wire
CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting
From CareDx, Inc.
Via Business Wire
CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting
From CareDx, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.